News

The latest on managing care, value-based care, insurance markets, payers & providers

Huge exposé this morning in Stat (which relies heavily on data collected by ProPublica) about the dearth of black patients in clinical trials for breakthrough drugs. As the length of the piece suggests, it’s a complex issue with many variables in play. The authors start off with multiple myeloma:…
Thousands of foster children may be getting powerful psychiatric drugs prescribed to them without basic safeguards, according to a report released by the Health and Human Services (HHS) inspector general’s office. The report found that about 1 in 3 foster kids from a sample of states were prescribed…
The FDA has approved a device intended to treat acute coronary artery perforations that can occur during percutaneous coronary intervention (PCI) procedures. The PK Papyrus Covered Coronary Stent System (Biotronik) is the first device approved for this indication in 17 years. The PK Papyrus stent system…
The FDA has discovered a new impurity in three lots of Torrent Pharmaceuticals’ recalled valsartan drug products. This second impurity, N-Nitrosodiethylamine (NDEA), is a known animal and suspected human carcinogen. These Torrent products were included in the company’s earlier recall on August…
Lumoxiti injection (moxetumomab pasudotox-tdfk, Astra Zeneca) has been approved to treat certain instances of relapsed or refractory "hairy cell" leukemia (HCL) in adults. The new drug is the latest addition to a novel class of drugs called CD22-directed cytotoxins to treat HCL, the FDA announced. The…
In what has been called a possible game-changing development in health care, the Department of Justice today approved of Cigna’s proposed purchase of the biggest PBM in the country, Express Scripts. The top dogs at both companies did not waste time voicing their excitement in a statement. Cigna President…
The New England Journal of Medicine (NEJM) describes the recent brouhaha over a paper it published a dispute that the author H. Gilbert Welch, MD, and the two researchers who claim Welch plagiarized them must settle on their own. The researchers who claim Welch plagiarized them—Samir Soneji, PhD,…
Well, here’s a real eye-opener for you: Getting a needle in the eye. Sure, it makes you flinch, but for millions of Medicare beneficiaries getting an injection of Eylea can help them retain vision. As Kaiser Health News reports, Medicare spent $2.2 billion on the drug in 2016 to treat patients with…